{
    "root": "0793fd3b-1fa1-4ef3-ae2f-756ef19ecc56",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "TRANEXAMIC ACID IN SODIUM CHLORIDE",
    "value": "20231130",
    "ingredients": [
        {
            "name": "TRANEXAMIC ACID",
            "code": "6T84R30KC1"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "indications": "tranexamic acid 0.7 % sodium chloride injection indicated patients hemophilia short-term ( two eight days ) reduce prevent hemorrhage reduce need replacement therapy following tooth extraction .",
    "contraindications": "extraction : administer 10 mg/kg actual body weight tranexamic acid 0.7 % sodium chloride injection intravenously replacement therapy . extraction : administer 10 mg/kg actual body weight 3 4 times daily 2 8 days . infuse 10 ml/minute avoid hypotension . ( 2.1 ) reduce patients renal impairment . ( 2.2 , 8.6 )",
    "warningsAndPrecautions": "tranexamic acid 0.7 % sodium chloride injection , 1,000 mg per 100 ml ( 10 mg per ml ) supplied sterile , unpreserved , clear , colorless solution single-dose polymeric bag containing 1,000 mg tranexamic acid 100 ml solution sealed twist-off port oversealed aluminum pouch . available follows : strength unit sale 1,000 mg per 100 ml ( 10 mg per ml ) ndc 80830-2329-1 1 single-dose infusion bag overwrap ndc 80830-2329-2 unit 10 ndc 80830-2329-3 unit 12 store 20° 25°c ( 68° 77°f ) ; excursions permitted 15° 30°c ( 59° 86°f ) [ usp controlled room temperature ] . discard unused portion .",
    "adverseReactions": "tranexamic acid 0.7 % sodium chloride injection contraindicated : patients subarachnoid hemorrhage . anecdotal experience indicates cerebral edema cerebral infarction may caused tranexamic acid patients . patients active intravascular clotting [ ( 5.1 ) ] . patients hypersensitivity tranexamic acid ingredients [ ( 5.3 ) ] .",
    "indications_original": "Tranexamic acid in 0.7% sodium chloride injection is indicated in patients with hemophilia for short-term use (two to eight days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.",
    "contraindications_original": "Before Extraction: Administer 10 mg/kg actual body weight of tranexamic acid in 0.7% sodium chloride injection intravenously with replacement therapy. After Extraction: Administer 10 mg/kg actual body weight 3 to 4 times daily for 2 to 8 days. Infuse no more than 10 mL/minute to avoid hypotension. ( 2.1 ) Reduce the dosage for patients with renal impairment. ( 2.2 , 8.6 )",
    "warningsAndPrecautions_original": "Tranexamic Acid in 0.7% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg per mL) is supplied as a sterile, unpreserved, clear, colorless solution in a single-dose polymeric bag containing 1,000 mg tranexamic acid in 100 mL of solution sealed with a Twist-off port and oversealed in an aluminum pouch.\n                  It is available as follows:\n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                              \n                                 Strength\n                              \n                           \n                           \n                              \n                                 Each\n                              \n                           \n                           \n                              \n                                 Unit of Sale\n                              \n                           \n                        \n                        \n                           \n                              \n                                 \n                                    1,000 mg per 100 mL\n                                 \n                              \n                              (10 mg per mL)\n                           \n                           \n                              NDC 80830-2329-1\n                              1 Single-dose Infusion Bag in an Overwrap\n                           \n                           \n                              NDC 80830-2329-2\n                              Unit of 10\n                           \n                        \n                        \n                            \n            NDC 80830-2329-3\n            Unit of 12\n                        \n                     \n                  \n                  Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Discard any unused portion.",
    "adverseReactions_original": "Tranexamic acid in 0.7% sodium chloride injection is contraindicated: \n                  \n                     In patients with subarachnoid hemorrhage. Anecdotal experience indicates that cerebral edema and cerebral infarction may be caused by tranexamic acid in such patients. \n                     In patients with active intravascular clotting [see Warnings and Precautions (5.1)].\n                     In patients with hypersensitivity to tranexamic acid or any of the ingredients [see Warnings and Precautions (5.3)]."
}